Achievement of major molecular response by 24 months based on molecular responses at 3 and 6 months.29
Reprinted by permission from Macmillan Publishers Ltd: Leukemia. Branford S, Rudzki Z, Harper A, et al. Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. 2003;17(12):2401–2409, © 2003